TB-500 is a synthetic research peptide derived from Thymosin Beta-4, widely utilized in controlled in-vitro laboratory studies to investigate mechanisms related to cell migration, cytoskeletal organization, and extracellular matrix (ECM) signaling under non-clinical research conditions.
By reproducing key functional domains of Thymosin Beta-4, TB-500 serves as a valuable tool for studying actin dynamics, cellular motility, tissue modeling, and signal regulation involved in cellular repair and structural organization at the molecular level.
Product name: TB-500
Synonyms: Thymosin beta-4 fragment; TB4 fragment peptide
Class: Peptide fragment (research use)
Form: Lyophilised powder
Appearance: White to off-white solid
Note: Identity and physicochemical properties may vary depending on salt form, counter-ion, and hydration state
All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal use.
🧪 Cell Migration & Motility Studies
Investigation of directional cell movement
Analysis of wound-closure and migration assays
⚗️ Cytoskeletal Dynamics Research
Evaluation of actin polymerization and depolymerization
Study of intracellular structural remodeling
🧩 Extracellular Matrix Signalling
Assessment of cell–matrix interactions
ECM-mediated signaling pathway analysis
🔒 Peptide Stability & Degradation Testing
Thermal, enzymatic, and chemical stability evaluation
Resistance to proteolytic breakdown in experimental models
📦 Formulation & Carrier System Research
Compatibility testing with research-grade excipients
Evaluation of encapsulation systems for controlled delivery
🧬 Cell-Based & Molecular Assays
Use in in-vitro culture systems
Support for mechanistic, translational, and pre-formulation research